ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 102 filers reported holding ENZO BIOCHEM INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $80,000 | -76.7% | 37,888 | -54.6% | 0.00% | – |
| Q3 2018 | $344,000 | -45.4% | 83,524 | -31.2% | 0.00% | -100.0% |
| Q2 2018 | $630,000 | +10.7% | 121,356 | +16.9% | 0.00% | 0.0% |
| Q1 2018 | $569,000 | -0.4% | 103,797 | +48.0% | 0.00% | 0.0% |
| Q4 2017 | $571,000 | +3.1% | 70,113 | +32.6% | 0.00% | 0.0% |
| Q3 2017 | $554,000 | +702.9% | 52,868 | +132.9% | 0.00% | – |
| Q2 2015 | $69,000 | +3.0% | 22,700 | 0.0% | 0.00% | – |
| Q1 2015 | $67,000 | -66.2% | 22,700 | -49.0% | 0.00% | – |
| Q4 2014 | $198,000 | -6.2% | 44,500 | +8.5% | 0.00% | -100.0% |
| Q3 2014 | $211,000 | +154.2% | 41,000 | +159.5% | 0.00% | – |
| Q2 2014 | $83,000 | – | 15,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |